Following its widespread use in the pharmaceutical sector in recent years, CBD has now entered the food sector and is present in several products available for consumption. In its July meeting, the COT discussed the available ADME, therapeutic effects and toxicological data on CBD and its current legal status in the UK.

UK Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment (2019). Scoping paper on the potential adverse effects of CBD products. COT meeting: 2 July 2019. TOX/2019/32.


The above items were taken from the October 2019 issue of Toxicology and Regulatory News which is sent automatically to members of bibra.

News Home Guest Write For Us? Contact Us